BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Medical Device Manufacturers Association (MDMA): Suspect GPO-hospital Deals Cost Taxpayers $38B Annually


10/8/2010 6:56:59 AM

WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- Hospitals spend more each year on medical devices and equipment that are purchased through Group Purchasing Organizations (GPOs) than they would if purchased in the open-market according to a recent study commissioned by the Medical Device Manufacturers Association (MDMA). The study empirically shows that GPOs fail to deliver on their primary justification for allowing them to receive kickbacks from suppliers, and that they do not in fact reduce costs.

(Logo: http://photos.prnewswire.com/prnh/20070227/DCTU110LOGO )

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/DCTU110LOGO )

"It is painfully clear that while hospitals and providers are trying to improve care and reduce costs for patients, the supplier-funded GPO model is costing the health care system billions," said MDMA President and CEO Mark Leahey. "This study proves that GPOs not only fail to bend the cost curve for health care down, they are preventing hospitals and patients from getting the best products at the best prices.

"This study bolsters our argument that Congress must pass legislation that will restore the illegality of kickbacks between suppliers and GPOs," added Leahey.

The study, "Do Group Purchasing Organizations Achieve the Best Prices for Member Hospitals? An Empirical Analysis of Aftermarket Transactions," found that repealing the safe harbor statutes Congress passed in 1986 would reduce private U.S. health care expenditures by up to $25 billion each year. This would also reduce federal health care spending by approximately $11.5 billion annually. Aftermarket transactions show that GPO member hospitals and health care providers would save up to $37.5 billion based on 2010's most recent data.

Other key findings of the study include:

Hospitals saved an average of 10 percent between 2001 through 2010 when they purchased medical devices aftermarket, when GPOs supposedly negotiated the best price; In 2010, the savings for hospitals was up to 18 percent for aftermarket purchases.

This groundbreaking study follows a 2009 report that showed hospitals could save approximately $8 billion each year if the safe harbor provisions were removed for GPOs.

GPOs were established to save hospitals money on the purchase of supplies and equipment. For decades hospitals funded these GPOs. However, with the creation of a safe harbor by Congress in 1986, the GPOs became reliant on suppliers for funding.

The Congressional exemption allows GPOs to legally collect fees from suppliers to whom they award contracts. Contractual arrangements that have evolved between GPOs and their hospital customers frequently exclude competitive medical technologies that could help patients and allow hospitals to reduce costs.

The full study is available at www.medicaldevices.org.

MDMA is a national trade association based in Washington, DC, representing hundreds of innovative, entrepreneurial companies in the medical device industry. MDMA seeks to improve the quality of patient care by encouraging the development of new medical technologies and fostering the availability of innovative products in the marketplace.

SOURCE Medical Device Manufacturers Association

Read more: http://www.kansascity.com/2010/10/06/2282184/gpos-fail-to-provide-hospitals.html#ixzz11lvgdfFu



Read at PR Newswire

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES